Cerebral Palsy - Pipeline Review, H1 2015

Cerebral palsy, in short, is also referred to as CP. It is a set of permanent disorders affecting human movements. CP may appear during early childhood. Symptoms & indications of this illness range from one person to another. Majority of the times, the signs comprise tight muscles, poor skills, tremors, and weak muscles. Cerebral palsy patients may also have issues regarding vision, sensations, hearing, swallowing food, and speaking.

Quite frequently, babies with this condition are unable to crawl, turn over, sit, or walk like other children their age. Seizures and reasoning/thinking problems also arise in around one-third CP patients. Whilst the indications are evident in the initial years of one’s life, primary issues do not deteriorate with time. Rising CP incidences around the globe are projected to propel the cerebral palsy market in the near future.

The common cause of CP is damage to brain parts that control body balance, movements, and postures. Abnormal brain growth may also lead to cerebral palsy. Quite frequently, issues occur before, immediately after, or during birth. Some other times, CP causes are unknown. However, according to researchers, CP may also result from weak oxygen supply to the brain during, before, or instantly after birth. 

Cerebral palsy may also be a consequence of birth injuries & infections. It can be partially avoided by mothers being vaccinated and children being prevented from head injuries. CP remains incurable till date. However, medicines, supportive therapeutics, and surgeries could assist several patients. These consist of occupational therapy, speech therapy, and physical therapy. Medicines like baclofen, diazepam, & botulinum toxin can assist in loosening stiff muscles. 

Surgeries may involve slicing hyperactive nerves and enlarging the muscles. Other innovative technologies and external braces are useful in some other cases. Few children may be able to lead normal lives post their treatments. Quite often, alternative medications are used to treat this condition. However, there is no proof to back their adoption. Cerebral palsy is the most widely prevalent movement disorder in children. 

Increasing incidences of brain damages, anomalies, abnormalities, & defects during/after/before birth are also anticipated to drive the cerebral palsy market. CP is of three kinds. These include athetoid, spastic, and ataxic.  

Scope

- The report provides a snapshot of the global therapeutic landscape of Cerebral Palsy
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Cerebral Palsy and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Cerebral Palsy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Cerebral Palsy pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Cerebral Palsy
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Cerebral Palsy pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline